IRVINE, Calif. Teva Health Systems has introduced its adenosine injection, USP in a pre-filled syringe, the company announced Wednesday.
Teva’s adenosine is AP rated to Astellas Pharma’s Adenocard IV Injection and is available in 2 ml and 3 mg per ml pre-filled syringes. Teva already markets 3 mg per ml and 2 ml and 4 ml single-dose vials of adenosine. Adenosine is designed to treat paroxysmal supraventricular tachycardia, a heart condition.
“Teva offers a broad range of quality health systems generics from a single source,” Teva director of marketing Jennifer Guzman said. “We are pleased to announce this latest addition to our growing line.”